NasdaqCM - Delayed Quote USD
Curis, Inc. (CRIS)
1.4300
+0.1300
+(10.00%)
At close: April 22 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-39,563
-39,563
-38,434
-54,337
-37,619
Investing Cash Flow
29,442
29,442
37,786
33,023
-47,895
Financing Cash Flow
3,437
3,437
7,580
867
-4,172
End Cash Position
20,541
20,541
27,225
20,293
40,740
Interest Paid Supplemental Data
461
461
2,359
4,112
4,437
Capital Expenditure
--
--
--
-416
--
Issuance of Capital Stock
12,023
12,023
14,117
5,842
--
Free Cash Flow
-39,563
-39,563
-38,434
-54,753
-37,619
12/31/2021 - 8/1/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RIGL Rigel Pharmaceuticals, Inc.
17.74
+4.78%
KPTI Karyopharm Therapeutics Inc.
6.03
+11.67%
GBIO Generation Bio Co.
0.4095
-1.80%
ATXI Avenue Therapeutics, Inc.
0.2700
+8.00%
SPRC SciSparc Ltd.
0.2746
+0.59%
DSGN Design Therapeutics, Inc.
3.9600
+10.31%
LPTX Leap Therapeutics, Inc.
0.3860
+7.34%
ENTX Entera Bio Ltd.
1.9600
+6.52%
FOLD Amicus Therapeutics, Inc.
6.91
+2.98%
TCRX TScan Therapeutics, Inc.
1.5700
+2.61%